Leading Executives in Biotechnology
Stéphane Bancel
Chief Executive Officer, Moderna
CEO since 2011 who helped scale Moderna from startup to a global mRNA medicines leader and was elected to the U.S. National Academy of Engineering in 2024 for contributions to development and manufacturing of pharmaceutical products, including the COVID-19 vaccine.
Website (company bio) | LinkedIn | X (company)
Albert Bourla
Chairman & Chief Executive Officer, Pfizer
Long‑tenured Pfizer leader serving as Chairman & CEO, recognized for steering the company’s science‑driven transformation and public engagement.
Website (company bio) | LinkedIn | X
Robert A. Bradway
Chairman & Chief Executive Officer, Amgen
Veteran biotech operator who has led Amgen as Chairman & CEO for more than a decade, guiding one of the world’s largest pure‑play biotechs.
Website (company bio) | Investor bio | X (company)
Steve Chapman
Chief Executive Officer, Natera
Cell‑free DNA testing champion who became CEO in 2019 and expanded Natera’s oncology (Signatera), women’s health (Panorama) and organ health offerings.
Website (company bio) | Press (bio/awards) | LinkedIn
Kevin Conroy
Chairman & Chief Executive Officer, Exact Sciences
Chairman & CEO since 2009 who built Exact Sciences into a cancer diagnostics leader behind Cologuard and a broader multi‑cancer early detection pipeline.
Website (company bio) | X (company) | LinkedIn (company)
Helmy Eltoukhy
Co‑Chief Executive Officer & Chairman, Guardant Health
Co‑founder, Chairman & co‑CEO who helped pioneer liquid‑biopsy diagnostics and launch the Shield blood‑based screening platform; named to the 2025 TIME100 Health list.
Website (company bio) | Press (recognition) | X (company)
Chris Gibson
Co‑Founder & Chief Executive Officer, Recursion
Co‑founder & CEO of a TechBio company that applies automation, proprietary datasets and AI to drug discovery; in 2025, advanced a combination with Exscientia to expand its AI pipeline.
Website (company bio) | Press (IR) | X (company)
Yvonne Greenstreet
Chief Executive Officer, Alnylam Pharmaceuticals
Biopharma veteran appointed CEO in late 2021, leading the first‑in‑class RNAi therapeutics company through commercial growth and late‑stage pipeline advances.
Website (company bio) | LinkedIn (company) | X (company)
Alexander Hardy
President & Chief Executive Officer, BioMarin Pharmaceutical
Former Genentech CEO who took the helm at BioMarin in December 2023 to accelerate growth in rare‑disease medicines including gene therapy and enzyme‑replacement therapies.
Website (company bio) | Press (transition) | X (company)
Jason Kelly
Co‑Founder & Chief Executive Officer, Ginkgo Bioworks
Co‑founder & CEO who popularized the ‘foundry’ model for programming cells across industries, helping make synthetic biology a horizontal platform.
Website (about) | Wikipedia (key people) | LinkedIn (company)
Reshma Kewalramani
Chief Executive Officer & President, Vertex Pharmaceuticals
Physician‑executive who became Vertex’s CEO and President in 2020, steering breakthrough cystic fibrosis medicines and, with CRISPR Therapeutics, the first FDA‑approved CRISPR‑based therapy (CASGEVY) in December 2023.
Website (company bio) | FDA (product milestone) | X (company)
Samarth Kulkarni
Chief Executive Officer & Chairman of the Board, CRISPR Therapeutics
Gene‑editing strategist who became CEO in 2017 and now also Chairs the Board; co‑led development (with Vertex) of CASGEVY, the first FDA‑approved CRISPR/Cas9 therapy.
Website (company bio) | FDA (product milestone) | X (company)
Emily Leproust
Chief Executive Officer & Co‑Founder, Twist Bioscience
Co‑founder & CEO recognized as a pioneer of high‑throughput DNA synthesis, enabling broad applications from therapeutics to NGS and data storage.
Website (company bio) | X (company) | LinkedIn (company)
Ugur Sahin
Co‑Founder & Chief Executive Officer, BioNTech
Physician‑scientist and BioNTech co‑founder who led “Project Lightspeed,” delivering the first authorized mRNA COVID‑19 vaccine and advancing individualized cancer immunotherapies.
Website (company board) | LinkedIn (company) | X (company)
Leonard S. Schleifer
Board Co‑Chair, President & Chief Executive Officer, Regeneron Pharmaceuticals
Neurologist‑entrepreneur who co‑founded Regeneron in 1988 and still serves as President & CEO, building a pipeline that includes ophthalmology and immunology blockbusters.
Website (company leadership) | Press (bio) | X (company)
Serge Saxonov
Chief Executive Officer & Co‑Founder, 10x Genomics
Co‑founder & CEO who helped create the single‑cell and spatial genomics category that transformed how researchers profile cells at scale.
Website (company bio) | X (company) | LinkedIn (company)
Jacob Thaysen
Chief Executive Officer, Illumina
Genomics tools executive appointed CEO in September 2023 to lead the sequencing market’s best‑known brand through its next phase of growth.
Website (company management) | Press (CEO appointment) | X (company)
Jan van de Winkel
President & Chief Executive Officer, Genmab
Co‑founder who serves as President & CEO, credited with building a prolific antibody company with major royalty streams (e.g., DARZALEX, Kesimpta) and first‑in‑class/next‑gen programs.
Press/IR (CEO confirmation) | Press (H1 2025 results) | X (company)
Chris Viehbacher
President & Chief Executive Officer, Biogen
Seasoned global pharma leader who became Biogen’s President & CEO in November 2022, focusing the neuroscience portfolio and commercial execution.
Website (company bio) | X (company) | LinkedIn (company)
Ryan J. Watts
President & Chief Executive Officer, Denali Therapeutics
Co‑founder & CEO advancing a blood‑brain barrier ‘Transport Vehicle’ platform with late‑stage programs (e.g., in MPS II) aimed at neurodegenerative and lysosomal diseases.
Website (company leadership) | Press/SEC (CEO references) | LinkedIn (company)
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.